Capital International Investors’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,113,749	Closed	-$11.7M	–	458
2024 Q1	$11.7M	Hold	3,113,749	–	–	﹤0.01%	395
2023 Q4	$30.5M	Hold	3,113,749	–	–	0.01%	358
2023 Q3	$26M	Sell	3,113,749 -1,102,052	-26%	-$12.6M	0.01%	361
2023 Q2	$56.1M	Hold	4,215,801	–	–	0.01%	330
2023 Q1	$48.8M	Sell	4,215,801 -1,883,880	-31%	-$18.7M	0.01%	339
2022 Q4	$49.9M	Sell	6,099,681 -2,349,477	-28%	-$20.2M	0.01%	327
2022 Q3	$49M	Sell	8,449,158 -3,126,338	-27%	-$17.9M	0.01%	336
2022 Q2	$51.2M	Sell	11,575,496 -1,206,359	-9%	-$7.33M	0.01%	345
2022 Q1	$116M	Buy	12,781,855 +675,537	+6%	+$7.78M	0.03%	294
2021 Q4	$248M	Buy	12,106,318 +712,191	+6%	+$17.2M	0.05%	249
2021 Q3	$291M	Buy	11,394,127 +2,616,823	+30%	+$77.5M	0.07%	225
2021 Q2	$307M	Buy	8,777,304 +840,179	+11%	+$24.4M	0.07%	213
2021 Q1	$264M	Sell	7,937,125 -1,870,901	-19%	-$65.5M	0.07%	215
2020 Q4	$254M	Sell	9,808,026 -931,806	-9%	-$15.8M	0.07%	215
2020 Q3	$106M	Buy	10,739,832 +3,943,532	+58%	+$22.7M	0.03%	262
2020 Q2	$23.4M	Hold	6,796,300	–	–	0.01%	346
2020 Q1	$20.8M	Buy	6,796,300 +1,514,500	+29%	+$6.2M	0.01%	318
2019 Q4	$27.1M	Buy	+5,281,800	New	+$26.8M	0.01%	301
2019 Q1	–	Sell	-2,080,000	Closed	-$15.4M	–	391
2018 Q4	$15.4M	Sell	2,080,000 -2,082,441	-50%	-$13.2M	0.01%	322
2018 Q3	$22.5M	Buy	+4,162,441	New	+$17.9M	0.01%	320